Menu Back to Marketing-Pharmaceuticals-2014-Regulating-Drug-Marketing-in-the-Ever-Changing-Regulatory-Legal-Health-Care-Environment

Program Committee

  • Thomas W. Abrams, MBA, RPh
    Thomas W. Abrams, MBA, RPh Director, Office of Prescription Drug Promotion, OMP, CDER FDA, United States
  • Glenn N.  Byrd, MBA, RAC
    Glenn N. Byrd, MBA, RAC Senior Director, Promotional Regulatory Affairs AstraZeneca Specialty Care, United States
  • Mark  Gaydos
    Mark Gaydos VP & Head, US Specialty Care 2, North America & Global Regulatory Affairs   Sanofi US, United States
  • John T. Murray
    John T. Murray President Grayscale Compliance LLC, United States
  • Michele  Hardy
    Michele Hardy Vice President, Regulatory Advertising and Promotion Policy GlaxoSmithKline, United States
  • Wayne L. Pines
    Wayne L. Pines President, Regulatory Services and Healthcare APCO Worldwide Inc., United States
  • Janet "Lucy"  Rose, MBA
    Janet "Lucy" Rose, MBA President Lucy Rose and Associates, LLC, United States
  • Kristina   Vlaovic, MPH
    Kristina Vlaovic, MPH Global Regulatory Franchise Head - Ophthalmology & Respiratory Genentech, A Member of the Roche Group, United States
  • Dale  Cooke
    Dale Cooke PhillyCooke Consulting , United States
Load More